These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4345716)

  • 1. Effect of a converting enzyme inhibitor (SQ 20,881) on angiotensin-induced drinking.
    Severs WB; Summy-Long J; Daniels-Severs A
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):203-4. PubMed ID: 4345716
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of converting enzyme blockade on isoprenaline- and angiotensin I-induced drinking.
    Hertting G; Meyer DK
    Br J Pharmacol; 1974 Nov; 52(3):381-6. PubMed ID: 4376436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.
    Collier JG; Robinson BF; Vane JR
    Lancet; 1973 Jan; 1(7794):72-4. PubMed ID: 4118651
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin-angiotensin role in thirst: paradoxical enhancement of drinking by angiotensin converting enzyme inhibitor.
    Lehr D; Goldman HW; Casner P
    Science; 1973 Dec; 182(4116):1031-4. PubMed ID: 4356029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an angiotensin converting enzyme inhibitor (SQ 14,225) on beta-adrenergic and angiotensin-induced thirsts.
    Katovich MJ; Barney CC; Fregly MJ; McCaa RE
    Eur J Pharmacol; 1979 Jun; 56(1-2):123-30. PubMed ID: 223856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitor and converting enzyme inhibitors suppress vascular angiotensin II.
    Saito H; Nakamaru M; Ogihara T; Rakugi H; Kumahara Y; Shimamoto K; Miyazaki M; Inagami T
    Hypertension; 1989 Jun; 13(6 Pt 2):749-53. PubMed ID: 2661430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of peptides inhibiting the angiotensin-converting enzyme of human seminal plasma.
    Depierre D; Bargetzi JP; Roth M
    Enzyme; 1979; 24(6):362-5. PubMed ID: 230029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin I converting enzyme inhibitor, SQ 14225, on renin production and release.
    Saruta T; Eguchi T; Yasui T; Nagahama S; Nakamura R; Kato E
    Nephron; 1981; 29(5-6):265-9. PubMed ID: 6172718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats.
    Wood JM; Mah SC; Schnell C
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S60-4. PubMed ID: 1705630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
    Bing J; Poulsen K
    Acta Pathol Microbiol Scand A; 1975 Sep; 83(5):454-66. PubMed ID: 170788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881.
    Duhme DW; Sancho J; Athanasoulis C; Haber E; Koch-Weser J
    Lancet; 1974 Mar; 1(7854):408. PubMed ID: 4136922
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 13. K-4, a novel inhibitor of angiotensin I converting enzyme produced by Actinomadura spiculosospora.
    Koguchi T; Yamada K; Yamato M; Okachi R; Nakayama K; Kase H
    J Antibiot (Tokyo); 1986 Mar; 39(3):364-71. PubMed ID: 3009378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Petide antagonists of the renin-angiotensin system in the characterisation of receptors for angiotensin-induced drinking.
    Fitzsimons JT; Epstein AN; Johnson AK
    Brain Res; 1978 Sep; 153(2):319-31. PubMed ID: 210883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of brain angiotensin-1 converting enzyme by Bothrops jararaca nonapeptide (SQ 20881) and a prolyl analog (SQ 14225).
    Benuck M; Marks N
    J Neurochem; 1978 Jun; 30(6):1653-5. PubMed ID: 209137
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of intrarenal and extrarenal converting-enzyme inhibition by SQ 20 881 on canine renal blood flow.
    Wong PC; Zimmerman BG
    Clin Sci (Lond); 1981 Nov; 61(5):553-7. PubMed ID: 6169480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Angiotensin inhibition.
    Chobanian AV
    N Engl J Med; 1974 Oct; 291(16):844-5. PubMed ID: 4371423
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of systemic and intracranial inhibition of angiotensin-converting enzyme on isoproterenol-induced drinking in the rat.
    Robinson MM; Evered MD
    Eur J Pharmacol; 1983 Jun; 90(4):343-8. PubMed ID: 6309534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intracerebroventricular administration of tonin on water intake and blood pressure in the rat.
    Kondo K; Garcia R; Boucher R; Genest J
    Brain Res; 1980 Nov; 200(2):437-41. PubMed ID: 6158365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.